Selected research
Industry Research
Dextran 20 Industry Research Report 2026
Market perspective
The global Dextran 20 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Dextran 20 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Dextran 20 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Dextran 20 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Dextran 20 include AAT, Aetna, Irvine Scientific, Mudanjiang Wanwei Pharmaceutical, Nanocs, Xian Ruixi Biological, Merck and Thermo Fisher, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Dextran 20 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dextran 20 Market by Company
AAT
Aetna
Irvine Scientific
Mudanjiang Wanwei Pharmaceutical
Nanocs
Xian Ruixi Biological
Merck
Thermo Fisher
Dextran 20 Segment by Type
50g/500ml
25g/250ml
10g/100ml
Others
Dextran 20 Segment by Application
Hospital
Clinic
Others
Dextran 20 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dextran 20 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dextran 20 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dextran 20.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dextran 20 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dextran 20 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dextran 20 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50g/500ml
- 25g/250ml
- 10g/100ml
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- AAT
- Aetna
- Irvine Scientific
- Mudanjiang Wanwei Pharmaceutical
- Nanocs
- Xian Ruixi Biological
- Merck
- Thermo Fisher
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dextran 20 Market Size (2021-2032)
- 2.2.2 Global Dextran 20 Sales (2021-2032)
- 2.2.3 Global Dextran 20 Market Average Price (2021-2032)
- 2.3 Dextran 20 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50g/500ml
- 2.3.3 25g/250ml
- 2.3.4 10g/100ml
- 2.3.5 Others
- 2.4 Dextran 20 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dextran 20 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dextran 20 Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Dextran 20 Revenue of Manufacturers (2021-2026)
- 3.4 Global Dextran 20 Average Price by Manufacturers (2021-2026)
- 3.5 Global Dextran 20 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dextran 20, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dextran 20, Product Type & Application
- 3.8 Global Manufacturers of Dextran 20, Established Date
- 3.9 Global Dextran 20 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AAT
- 4.1.1 AAT Company Information
- 4.1.2 AAT Business Overview
- 4.1.3 AAT Dextran 20 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AAT Dextran 20 Product Portfolio
- 4.1.5 AAT Recent Developments
- 4.2 Aetna
- 4.2.1 Aetna Company Information
- 4.2.2 Aetna Business Overview
- 4.2.3 Aetna Dextran 20 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Aetna Dextran 20 Product Portfolio
- 4.2.5 Aetna Recent Developments
- 4.3 Irvine Scientific
- 4.3.1 Irvine Scientific Company Information
- 4.3.2 Irvine Scientific Business Overview
- 4.3.3 Irvine Scientific Dextran 20 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Irvine Scientific Dextran 20 Product Portfolio
- 4.3.5 Irvine Scientific Recent Developments
- 4.4 Mudanjiang Wanwei Pharmaceutical
- 4.4.1 Mudanjiang Wanwei Pharmaceutical Company Information
- 4.4.2 Mudanjiang Wanwei Pharmaceutical Business Overview
- 4.4.3 Mudanjiang Wanwei Pharmaceutical Dextran 20 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mudanjiang Wanwei Pharmaceutical Dextran 20 Product Portfolio
- 4.4.5 Mudanjiang Wanwei Pharmaceutical Recent Developments
- 4.5 Nanocs
- 4.5.1 Nanocs Company Information
- 4.5.2 Nanocs Business Overview
- 4.5.3 Nanocs Dextran 20 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nanocs Dextran 20 Product Portfolio
- 4.5.5 Nanocs Recent Developments
- 4.6 Xian Ruixi Biological
- 4.6.1 Xian Ruixi Biological Company Information
- 4.6.2 Xian Ruixi Biological Business Overview
- 4.6.3 Xian Ruixi Biological Dextran 20 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Xian Ruixi Biological Dextran 20 Product Portfolio
- 4.6.5 Xian Ruixi Biological Recent Developments
- 4.7 Merck
- 4.7.1 Merck Company Information
- 4.7.2 Merck Business Overview
- 4.7.3 Merck Dextran 20 Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Dextran 20 Product Portfolio
- 4.7.5 Merck Recent Developments
- 4.8 Thermo Fisher
- 4.8.1 Thermo Fisher Company Information
- 4.8.2 Thermo Fisher Business Overview
- 4.8.3 Thermo Fisher Dextran 20 Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Thermo Fisher Dextran 20 Product Portfolio
- 4.8.5 Thermo Fisher Recent Developments
5 Global Dextran 20 Market Scenario by Region
- 5.1 Global Dextran 20 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dextran 20 Sales by Region: 2021-2032
- 5.2.1 Global Dextran 20 Sales by Region: 2021-2026
- 5.2.2 Global Dextran 20 Sales by Region: 2027-2032
- 5.3 Global Dextran 20 Revenue by Region: 2021-2032
- 5.3.1 Global Dextran 20 Revenue by Region: 2021-2026
- 5.3.2 Global Dextran 20 Revenue by Region: 2027-2032
- 5.4 North America Dextran 20 Market Facts & Figures by Country
- 5.4.1 North America Dextran 20 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dextran 20 Sales by Country (2021-2032)
- 5.4.3 North America Dextran 20 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Dextran 20 Market Facts & Figures by Country
- 5.5.1 Europe Dextran 20 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dextran 20 Sales by Country (2021-2032)
- 5.5.3 Europe Dextran 20 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Dextran 20 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dextran 20 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dextran 20 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dextran 20 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dextran 20 Market Facts & Figures by Country
- 5.7.1 South America Dextran 20 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dextran 20 Sales by Country (2021-2032)
- 5.7.3 South America Dextran 20 Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Dextran 20 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dextran 20 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dextran 20 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dextran 20 Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Dextran 20 Sales by Type (2021-2032)
- 6.1.1 Global Dextran 20 Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Dextran 20 Sales Market Share by Type (2021-2032)
- 6.2 Global Dextran 20 Revenue by Type (2021-2032)
- 6.2.1 Global Dextran 20 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dextran 20 Revenue Market Share by Type (2021-2032)
- 6.3 Global Dextran 20 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dextran 20 Sales by Application (2021-2032)
- 7.1.1 Global Dextran 20 Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Dextran 20 Sales Market Share by Application (2021-2032)
- 7.2 Global Dextran 20 Revenue by Application (2021-2032)
- 7.2.1 Global Dextran 20 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dextran 20 Revenue Market Share by Application (2021-2032)
- 7.3 Global Dextran 20 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dextran 20 Value Chain Analysis
- 8.1.1 Dextran 20 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dextran 20 Production Mode & Process
- 8.2 Dextran 20 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dextran 20 Distributors
- 8.2.3 Dextran 20 Customers
9 Global Dextran 20 Analyzing Market Dynamics
- 9.1 Dextran 20 Industry Trends
- 9.2 Dextran 20 Industry Drivers
- 9.3 Dextran 20 Industry Opportunities and Challenges
- 9.4 Dextran 20 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst